Heterocyclic aromatic amine [hca] intake and prostate cancer risk: Effect modification by genetic variants

Nutrition and Cancer

Volumn 64, Issue 5, 2012, Pages 704-713

  Hemelrijck, Mieke Van ^a   Rohrmann, Sabine ^b,c   Steinbrecher, Astrid ^c   Kaaks, Rudolf ^c,d   Teucher, Birgit ^d   Linseisen, Jakob ^c,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,4,8 DIMETHYLIMIDAZO [4,5 F]QUINOXALINE; AROMATIC AMINE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HETEROCYCLIC AMINE; MANGANESE SUPEROXIDE DISMUTASE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; COOKING; DIETARY INTAKE; DNA MODIFICATION; FAMILY HISTORY; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEAT; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AMINES; CARCINOGENS; CASE-CONTROL STUDIES; COHORT STUDIES; COOKING; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GERMANY; GLUTATHIONE TRANSFERASE; HETEROCYCLIC COMPOUNDS; HUMANS; HYDROCARBONS, AROMATIC; MALE; MEAT; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK; SUPEROXIDE DISMUTASE;

EID: 84863706815     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.678548     Document Type: Article

References (32)

1. ZhengWand Lee SA:Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61, 437-446, 2009.
2. Alexander DD, Mink PJ, Cushing CA, and Sceurman B: A review and meta-Analysis of prospective studies of red and processed meat intake and prostate cancer. Nutr J 9, 50, 2010.
3. Tang D, Liu JJ, Rundle A, Neslund-Dudas C, Savera AT, et al.: Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomarkers Prev 16, 803-808, 2007.
4. Creton SK, Zhu H, and Gooderham NJ: The cooked meat carcinogen 2-Amino-1-methyl-6-phenylimidazoo[4,5-b]pyridine activates the extracellular signal regulated kinase mitogen-Activated protein kinase pathway. Cancer Res 67, 11455-11462, 2007.
5. Cross AJ, Peters U, Kirsh VA, Andriole GL, Reding D, et al.: A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 65, 11779-11784, 2005.
6. Norrish AE, Ferguson LR, Knize MG, Felton JS, Sharpe SJ, et al.: Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst 91, 2038-2044, 1999.
7. Rovito PM, Jr., Morse PD, Spinek K, Newman N, Jones RF, et al.: Heterocyclic amines and genotype of N-Acetyltransferases as risk factors for prostate cancer. Prostate Cancer Prostatic Dis 8, 69-74, 2005.
8. Koutros S, Cross AJ, Sandler DP, Hoppin JA, Ma X, et al.: Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev 17, 80-87, 2008.
9. Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, et al.: Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol 170, 1165-1177, 2009.
10. Rohrmann S, Zoller D, Hermann S, and Linseisen J: Intake of heterocyclic aromatic amines from meat in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr 98, 1112-1115, 2007.
11. Sander A, Linseisen J, and Rohrmann S: Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort. Cancer Causes Control 22, 109-114, 2011.
12. Wang CY, Debiec-Rychter M, Schut HA, Morse P, Jones RF, et al.: Nacetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. Carcinogenesis 20, 1591-1595, 1999.
13. Koutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, et al.: Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 69, 1877-1884, 2009.
14. Sharma S, Cao X, Wilkens LR, Yamamoto J, Lum-Jones A, et al.: Welldone meat consumption,NAT1 andNAT2 acetylator genotypes and prostate cancer risk: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19, 1866-1870, 2010.
15. Gervasini G, San Jose C, Carrillo JA, Benitez J, and Cabanillas A: GST polymorphisms interact with dietary factors to modulate lung cancer risk: Study in a high-incidence area. Nutr Cancer 62, 750-758, 2010.
16. Boeing H, Korfmann A, and Bergmann MM: Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43, 205-215, 1999.
17. Riboli E: The European Prospective Investigation into Cancer and Nutrition (EPIC): Plans and progress. J Nutr 131, 170S-175S, 2001.
18. Bergmann MM, Bussas U, and Boeing H: Follow-up procedures in EPICGermany-data quality aspects: E uropean Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43, 225-234, 1999.
19. Rohrmann S and Becker N: Development of a short questionnaire to assess the dietary intake of heterocyclic aromatic amines. Public Health Nutr 5, 699-705, 2002.
20. Timofeeva M, Jager B, Rosenberger A, Sauter W, Wichmann HE, et al.: A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers. Clin BiochemCancer Epidemiol Biomarkers Prev 19, 2958-2968, 2010.
21. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, et al.: Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 19, 2958-2968, 2010.
22. Steinbrecher A, Rohrmann S, Timofeeva M, Risch A, Jansen E, et al.: Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 19, 135-143, 2010.
23. Di Paolo OA, Teitel CH, Nowell S, Coles BF, and Kadlubar FF: E xpression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetylcoA-, PAPS- and ATP-dependent pathways. Int J Cancer 117, 8-13, 2005.
24. Shaik AP, JamilK, and Das P: CYP1A1 polymorphisms and risk of prostate cancer: A meta-Analysis. Urol J 6, 78-86, 2009.
25. Nelson CP,Kidd LC, Sauvageot J, Isaacs WB,DeMarzo AM, et al.: Protection against 2-hydroxyamino-1-methyl-6-phenylimidazoo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61, 103-109, 2001.
26. Williams JA, Martin FL, Muir GH, Hewer A, Grover PL, et al.: Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21, 1683-1689, 2000.
27. Iguchi T, Sugita S, Wang CY, Newman NB, Nakatani T, et al.: MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status. In Vivo 23, 7-12, 2009.
28. Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA, et al.: Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Carcinogenesis 30, 968-976, 2009.
29. Agudo A, Peluso M, Sala N, Capella G, Munnia A, et al.: Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: Findings from the EPIC-Spain cohort. Carcinogenesis 30, 968-976, 2009.
30. Alaejos MS, Gonzalez V, and Afonso AM: E xposure to heterocyclic aromatic amines from the consumption of cooked red meat and its effect on human cancer risk: A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25, 2-24, 2008.
31. Mao C, Qiu LX, Zhan P, Xue K, Ding H, et al.:MnSOD Val16Ala polymorphism and prostate cancer susceptibility: A meta-Analysis involving 8,962 subjects. J Cancer Res Clin Oncol 136, 975-979, 2010.
32. Rohrmann S, Hermann S, and Linseisen J: Heterocyclic aromatic amine intake increases colorectal adenoma risk: Findings from a prospective European cohort study. Am J Clin Nutr 89, 1418-1424, 2009.